Huadong Medicine and PulseCath Announce Strategic Collaboration to Develop and Commercialize the iVAC mechanical circulatory product in Greater China

Partnership accelerates the development of the iVAC 2L mechanical circulatory device in Greater China. Expands Huadong Medicine’s medical portfolio for cases of high-risk PCI with innovative percutaneous ventricle assist devices based on innovative pulsatile technology. PulseCath will receive a significant investment in its share capital and in payments for regulatory and development activities and is eligible to royalties on iVAC’s commercial sales by Huadong Medicine in their commercial region. ARNHEM, THE NETHERLANDS and HANGZHOU, PRC, September 17, 2021 — PulseCath B.V., a leader in the expanding field of percutaneous ventricular assist devices for high-risk PCI, and Huadong Medicine Co., Ltd., today announced that the companies have entered into an exclusive collaboration to develop and commercialize the iVAC technology in mainland China, Hong Kong, Macau and Taiwan (Greater China) and selected other Asian Pacific countries. The collaboration agreement between PulseCath and Huadong provides Huadong Medicine with a license to distribute iVAC […]

Joint EAPCI/ACVC expert consensus document on pVAD

An expert consensus has been released by the Joint European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) reviewing the pathophysiological context and indications for pVADs in different clinical settings. It also provides guidance regarding the clinical management of patients requiring pVADs. A quick overview is made on the state-of-the art of short-term mechanical circulatory support according to different indications. Additional discussions on the handling of complications, anticoagulation and weaning are also provided. The appendix section describes the theoretical basis for the use of different MCS devices, including how their effects differ. The review has been published on EuroIntervention. Please follow this link for the full publication.

EuroPCR 2021: iVAC 2L case presentation by Dr. Ota Hlinomaz, CINRE, Bratislava, Slovak Republic

Dr. Ota Hlinomaz, interventional cardiologist at CINRE hospital in Slovak Republic presented during the EuroPCR 2021: Improving outcomes of high-risk protected distal left main intervention by pulsatile circulatory support system. For more information please follow this link.

Live Case iVAC 2L at Transcatheter Interventions Online April 2021

The recording of the live case iVAC 2L performed by Prof.Dr. Nicolas Van Mieghem and the team, Erasmus Medical Center, Rotterdam, Netherlands during the Mechanical Circulatory Support session at day 2 of the Transcatheter Interventions Online 2021 of last week is now available on demand.

CSI FOCUS D-HF: MECHANICAL CIRCULATORY SUPPORT March 2021

The recording of the CSI FOCUS D-HF: Mechanical circulatory support from March 2021 is now available on-demand. Feel free to share who may be interested.The presentation about PulseCath iVAC 2L by Prof.Dr. Nicolas van Mieghem, Erasmus Medical Center, Rotterdam, Netherlands starts at 01:40:42.

PulseCath at ACS Live Turkey 2020

Please follow these links to the webinars during ACS Live in Turkey 2020:

iVAC 2L in Mechanical Circulatory Support facilitated high-risk PCI

In November 2020 hosted by Prof. Dr. Nicolas M. Van Mieghem, MD, PhD, FACC, FESC Professor & Director of Interventional Cardiology Thoraxcenter, Erasmus University Medical Center Rotterdam, the Netherlands. Follow this link for the presentation

MCS using the iVAC 2L in high-risk PCI

Five sessions in November 2020 hosted by Dr. Joost Daemen, MD, PHD, FESC. Interventional cardiologist, Thoraxcenter, Erasmus Medical Center, the Netherlands. Please follow the link for the online webinar.

Meet Us At TCT 2019, Sep' 26-28 – Booth# 1757

Meet Us At TCT 2019, Sep’ 26-28 – Booth# 1757

Meet us at CSI congress Frankfurt June 26-29, 2019

https://www.csi-congress.org/event-calendar

News